Why previous systemic therapy needs its own explanation
A first-visit guide usually covers the whole journey: symptoms, diagnosis, surgery, recovery and follow-up. That broad overview is useful for orientation, but it does not give a treating team the specific information they need to assess whether a particular treatment worked or should be reconsidered. Previous systemic therapy is a distinct subject because it changes how clinicians interpret your current status and what options they may discuss.
Systemic therapy for breast cancer can include chemotherapy, endocrine therapy, targeted therapy and other drug treatments. Each has its own schedule, purpose and expected effect. When you present a summary that groups them together without dates or outcomes, the clinical team cannot tell whether a treatment was completed, stopped early, or changed because of side effects. That distinction matters for any review of your case in China.
The practical goal is not to retell your whole medical history. It is to give a concise, accurate account of the drug treatments you have received and what the results were. This helps the hospital decide what further assessment or discussion is appropriate. It also reduces the chance that you are asked to repeat information you already have.
What to include in a previous systemic therapy summary
A useful summary answers four questions for each treatment: what was given, when, why it was stopped or changed, and what the response was. The 'what' includes the drug name, the regimen if you know it, and the route of administration. The 'when' includes start and end dates, or at least the month and year. The 'why' covers whether the course was completed, whether it was stopped for side effects, or whether it was changed because of progression. The 'response' is what your treating team observed or recorded, such as imaging results, tumour marker trends or clinical notes.
You do not need to interpret these results yourself. Your role is to present the records clearly and let the receiving clinicians assess them. If you have discharge summaries, treatment records or clinic letters, those are more useful than a personal recollection. If some documents are missing, say so plainly rather than guessing.
It also helps to state what you understand your current status to be. For example, whether you are currently on treatment, between treatments, or have completed a course. This is not a request for advice. It is context that helps the clinical team understand where you are in your journey.
- Drug name and regimen, if known
- Start and end dates, or approximate months
- Reason the treatment stopped or changed
- Recorded response, such as imaging or clinical notes
- Current treatment status
Linking systemic therapy to biopsy and receptor reports
Systemic therapy decisions in breast cancer are closely tied to the receptor status of the tumour. Oestrogen receptor, progesterone receptor and HER2 status are usually recorded in the biopsy or surgical pathology report. These results help explain why a particular drug was chosen and whether a different approach might be considered now.
When you send records for a review in China, include the original pathology reports if you have them. If the reports are in another language, a translation may be needed, but ask the receiving hospital what they require before arranging anything. Do not assume that a summary you wrote yourself will replace the official report.
If the receptor status has changed over time, or if a new biopsy was taken after treatment, include that information too. A change in receptor status can affect how clinicians interpret previous treatment and what they might discuss next. This is a clinical judgement, not something you need to resolve before making contact.
Separating surgical history from systemic therapy history
Breast-conserving surgery and mastectomy remove different amounts of breast tissue, and reconstruction is a separate discussion. These are surgical facts, not systemic therapy facts, but they often appear together in a patient's records. When you write your summary, keep the two threads distinct so the clinical team can see what was treated with drugs and what was treated with surgery.
For the surgical part, state what operation you had and when. If you had reconstruction, say whether it was immediate or delayed, and whether it was completed. You do not need to describe the technique. The receiving team will ask for operative notes if they need more detail.
This separation matters because a review of previous systemic therapy is not the same as a review of surgical options. If your question is about surgery, say so. If your question is about whether a drug treatment should be reconsidered, say that instead. Clear framing helps the hospital route your enquiry to the right specialist.
What the receiving team still needs to confirm
No summary you write can replace the treating team's own assessment. They will need to confirm the details against your original records, and they may ask for additional tests or reports. This is normal. It does not mean your summary was inadequate. What matters is that the records you send are legible, dated and attributable to a named treating centre, so the reviewing clinicians can trace each drug course back to a source document rather than to your recollection.
Some questions cannot be answered from records alone. Whether a particular treatment is still appropriate depends on your current clinical status, which may require an examination or new imaging. The hospital decides suitability after reviewing your case. An initial enquiry does not establish eligibility for any specific treatment. It also does not confirm that a drug you received abroad is stocked, licensed or reimbursable in China; those are separate questions for the named hospital and its pharmacy, and you should ask them directly rather than assume an answer from your home experience.
A records-based review and a face-to-face consultation are different products. A records review can comment on the pattern of treatment you have already had and flag what is missing from the file. It cannot examine you, and it cannot settle whether you are fit for a specific procedure or drug. If your question depends on how you are now, say so in the enquiry so the team can tell you what further assessment would be needed.
If you are currently receiving treatment, do not stop or change it to travel. Any decision about ongoing care should be made with your current treating clinicians. An overseas review can provide additional perspective, but it does not replace local care. If your symptoms are worsening, local assessment takes priority over an overseas enquiry, and you should not delay it to assemble records.
One practical point about language: if your treatment records are in a language other than English or Chinese, ask the receiving hospital what translation format it accepts and who should certify it. Do not commission a certified translation before you know the requirement, because a hospital may accept a different format or may need the original alongside it. Ask the question first, then arrange the documents.
Finally, be explicit about what you want from the review. If you want a second opinion on whether a past regimen was appropriate, that is a different request from asking what options might exist now. Stating your actual question in one sentence helps the hospital route your file to the right specialist and reduces the chance of a reply that answers something you did not ask.
How to prepare and what to ask next
Start by gathering the documents you already have: pathology reports, treatment records, discharge summaries and recent imaging reports. Write a one-page summary that follows the structure above. Keep it factual and avoid speculation about why a treatment worked or did not work.
When you contact a hospital or coordination service, state clearly that you are seeking a review of previous systemic therapy for breast cancer. Ask what records they need and in what format. Ask whether a translation is required and who is responsible for arranging it. Ask what the next step is if your records are incomplete.
You can begin with a brief summary through the enquiry form, email or WhatsApp. The initial case review is free and does not require buying a proxy consultation. The team will check what you have provided, identify missing information and suggest a relevant next step. The hospital, not the coordination service, decides whether to accept your case and what treatment to recommend.
For more detail on surgical aspects of breast cancer care in China, see the breast surgery reference page. It covers the surgical side, while this guide focuses on explaining previous systemic therapy.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.